PDAC - Pancreatic Ductal Adenocarcinoma

specific

Pancreatic ductal adenocarcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment.

34

Centers

48

Active Trials

Cancer Funding

Top Centers for PDAC - Pancreatic Ductal Adenocarcinoma(34)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
72.6
2
High-Volume Research Center
72.6
3
NCI Comprehensive
High-Volume Research Center
70.0
4
NCI Comprehensive
High-Volume Research Center
70.0
5
NCI Comprehensive
Active Research Program
65.4
6
NCI Comprehensive
Active Research Program
65.4
7
NCI Comprehensive
Active Research Program
65.4
8
NCI Comprehensive
Active Research Program
65.4
9
Active Research Program
65.4
10
NCI Comprehensive
Active Research Program
46.2
11
NCI Comprehensive
Active Research Program
46.2
12
NCI Comprehensive
Active Research Program
46.2
13
NCI Comprehensive
Active Research Program
46.2
14
NCI Comprehensive
Active Research Program
46.2
15
NCI Comprehensive
Active Research Program
46.2
16
NCI Comprehensive
Active Research Program
46.2
17
NCI Comprehensive
Active Research Program
46.2
18
NCI Comprehensive
Active Research Program
46.2
19
NCI Comprehensive
Active Research Program
46.2
20
NCI Clinical
Active Research Program
46.2
21
NCI Comprehensive
Active Research Program
46.2
22
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
46.2
23
Stephenson Cancer CenterOklahoma City, OK
NCI Clinical
Active Research Program
46.2
24
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
46.2
25
Active Research Program
46.2
26
NCI Clinical
Active Research Program
46.2
27
NCI Comprehensive
Active Research Program
46.2
28
Active Research Program
46.2
29
Active Research Program
46.2
3046.2
31
BC CancerVancouver, BC
Active Research Program
46.2
32
Active Research Program
46.2
33
Active Research Program
46.2
34
NCI Comprehensive
29.6

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →